Literature DB >> 8784571

Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.

M A Pfaller1, S A Messer, A Bolmström, F C Odds, J H Rex.   

Abstract

A multicenter study was performed to establish the interlaboratory reproducibility of Etest, to provide an additional comparison of Etest MICs with reference broth macrodilution MICs, and to develop some tentative quality control (QC) guidelines for using Etest for antifungal susceptibility testing of Candida spp. Two QC strains, Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258, were tested by Etest against amphotericin B, fluconazole, flucytosine, itraconazole, and ketoconazole in each of four laboratories. The QC strains were tested 20 times each against the five antifungal agents by using a common lot of RPMI agar. A total of 80 MICs per drug per strain were generated during the study. Overall, 98 to 100% of the MICs fell within a 3 log2 dilution range for the respective yeast-antifungal agent combinations. The level of agreement of Etest MICs with broth macrodilution MICs was 86 to 100% with amphotericin B (C. krusei and C. parapsilosis), itraconazole (C. krusei and C. parapsilosis), flucytosine (C. parapsilosis), and fluconazole (C. parapsilosis). A lower level of agreement was observed with ketoconazole (C. krusei and C. parapsilosis). Although all participants reported identical Etest MICs, the MICs of flucytosine and fluconazole when tested against C. krusei fell well above the upper limits of the reference range for this strain. The tentative QC limits for the two QC strains and five antifungal agents when tested by the Etest methodology are the same as the QC limits when tested by the reference broth macrodilution method for amphotericin B and C. krusei, itraconazole and C. krusei, flucytosine and C. parapsilosis, fluconazole and C. parapsilosis, and itraconazole and C. parapsilosis. The Etest QC ranges are 1 dilution broader (4-dilution range) than the reference macrodilution method QC ranges for ketoconazole and C. krusei, amphotericin B and C. parapsilosis, and ketoconazole and C. parapsilosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784571      PMCID: PMC229096     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group.

Authors:  A L Barry; P C Fuchs; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Sep-Oct       Impact factor: 2.803

3.  Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.

Authors:  M A Pfaller; S A Messer; S Coffmann
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose.

Authors:  A Espinel-Ingroff; M Pfaller; M E Erwin; R N Jones
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

5.  Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole.

Authors:  J H Rex; M A Pfaller; M Lancaster; F C Odds; A Bolmström; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.

Authors:  M A Pfaller; M Bale; B Buschelman; M Lancaster; A Espinel-Ingroff; J H Rex; M G Rinaldi; C R Cooper; M R McGinnis
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.

Authors:  A Wanger; K Mills; P W Nelson; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Etest for antifungal susceptibility testing of yeasts.

Authors:  A Espinel-Ingroff
Journal:  Diagn Microbiol Infect Dis       Date:  1994-08       Impact factor: 2.803

9.  Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole.

Authors:  D L Sewell; M A Pfaller; A L Barry
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; A L Barry
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more
  18 in total

1.  Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia.

Authors:  C J Clancy; M H Nguyen
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Arv1 lipid transporter function is conserved between pathogenic and nonpathogenic fungi.

Authors:  Christina Gallo-Ebert; Paula C McCourt; Melissa Donigan; Michelle L Villasmil; WeiWei Chen; Devanshi Pandya; Judith Franco; Desiree Romano; Sean G Chadwick; Scott E Gygax; Joseph T Nickels
Journal:  Fungal Genet Biol       Date:  2011-11-27       Impact factor: 3.495

4.  Collaborative study of the NCCLS and flow cytometry methods for antifungal susceptibility testing of Candida albicans.

Authors:  Vishnu Chaturvedi; Rama Ramani; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.

Authors:  Borann Sar; Sambo Boy; Chantary Keo; Chan Chhaya Ngeth; Narom Prak; Mich Vann; Didier Monchy; Jean Louis Sarthou
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

6.  Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.

Authors:  E Dannaoui; S Colin; J Pichot; M A Piens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

7.  Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.

Authors:  A Espinel-Ingroff; M Pfaller; S A Messer; C C Knapp; S Killian; H A Norris; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.

Authors:  M A Pfaller; S A Messer; A Karlsson; A Bolmström
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.

Authors:  Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Bianca A Bouman; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis.

Authors:  Milce Costa; Xisto Sena Passos; André Thiago Borges Miranda; Rosane Silva Carneiro de Araújo; Claudete Rodrigues Paula; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2004-01       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.